TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33352599

Group type: EXPERIMENTAL
Intervention: Active recovery (cycling generated by the own subject)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Passive recovery (cycling generated by external force)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Inactive recovery (no-cycling)
Number of subjects: 25
Study: 36104179

Group type: EXPERIMENTAL
Intervention: LIPUS therapy (1.3 MPa, 32 cycles, 5% duty cycle, 1 hour, 3 times a week for 6 sessions over 1.5 years)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LIPUS therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 35032465

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control (no binder)
Number of subjects: 220
Study: 33933305

Group type: EXPERIMENTAL
Intervention: Approximating technique (AP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Overlapping technique (OV)
Number of subjects: 36
Study: 32422100

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0
Study: 35246404

Group type: EXPERIMENTAL
Intervention: CARE‐Express
Number of subjects: 71

Group type: COMPARATOR
Intervention: ESWC
Number of subjects: 71
Study: 32295890

Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS)
Number of subjects: 620
Study: 35124675

Group type: EXPERIMENTAL
Intervention: Multifactorial interdisciplinary intervention (physical exercise, Mediterranean diet advice, assessment of inadequate prescribing, social assessment) for 6 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care primary healthcare treatment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multifactorial interdisciplinary intervention
Number of subjects: 200
Study: 33090088

Group type: EXPERIMENTAL
Intervention: Telepresence robot (TP)
Number of subjects: 43

Group type: COMPARATOR
Intervention: In-person (IP)
Number of subjects: 43
Study: 32590064

Group type: EXPERIMENTAL
Intervention: Thigh-high compression stockings (CS) and sequential compression devices (SCDs)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sequential compression devices (SCDs) alone
Number of subjects: 66
Study: 34378269

Group type: EXPERIMENTAL
Intervention: Zirconia endocrowns
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Hybrid ceramic endocrowns
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lithium disilicate endocrowns
Number of subjects: 53

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 53
Study: 32294530

Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg every 2 weeks)
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Durvalumab plus tremelimumab (durvalumab 20 mg/kg q4w plus tremelimumab 1 mg/kg q4w × 4, then durvalumab 10 mg/kg q2w)
Number of subjects: 736

Group type: COMPARATOR
Intervention: Standard of care (SoC: cetuximab, a taxane, methotrexate, or a fluoropyrimidine)
Number of subjects: 736
Study: 35440449

Group type: EXPERIMENTAL
Intervention: Patient navigation (PN) intervention aimed at decreasing non‐adherence to receipt of infant hearing diagnosis within 3 months after birth.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient navigation (PN) intervention
Number of subjects: 0
Study: 33704831

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy (CP) including prolonged slow expiration (PSE) and assisted cough (AC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (medical treatment alone)
Number of subjects: 31
Study: 33030225

Group type: EXPERIMENTAL
Intervention: Low-Dose, Open Food Challenge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double-Blind, Placebo-Controlled Data
Number of subjects: 0
Study: 36364716

Group type: EXPERIMENTAL
Intervention: Food guiding booklet (G)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dinner set (D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dietary skills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher educational level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monthly income of 3000−5000
Number of subjects: 0
Study: 35854390

Group type: EXPERIMENTAL
Intervention: DELTA Xtend® Reverse Shoulder System Lateralized Glenosphere Line Extension
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard DELTA Xtend® Reverse Shoulder System
Number of subjects: 122
Study: 33992562

Group type: EXPERIMENTAL
Intervention: Baroreflex Activation Therapy (BAT) plus guideline-directed medical therapy (GDMT)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 264
Study: 32380138

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sham acupuncture (two forms)
Number of subjects: 102

Group type: COMPARATOR
Intervention: No-intervention usual care control
Number of subjects: 102
Study: 35143442

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) therapy combined with 4% hydroquinone (HQ) cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: 4% hydroquinone (HQ) cream alone
Number of subjects: 30
Study: 33586842

Group type: EXPERIMENTAL
Intervention: Surgery and adjuvant radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 32012053

Group type: EXPERIMENTAL
Intervention: Smart Management Strategy for Health-based electronic program (Smart Healthing)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Basic educational material concerning disease control
Number of subjects: 106
Study: 35787137

Group type: EXPERIMENTAL
Intervention: Activated prospective memory task with lower focality
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Activated prospective memory task with higher focality
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Deactivated prospective memory task with high process overlap in a zero-target condition
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Deactivated prospective memory task with lower focality
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Deactivated prospective memory task with higher focality
Number of subjects: 226
Study: 32103439

Group type: EXPERIMENTAL
Intervention: Intraventricularly delivered, sustained-release nimodipine (EG-1962)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Standard of care oral nimodipine (NEWTON 2)
Number of subjects: 5
Study: 34057590

Group type: EXPERIMENTAL
Intervention: Severe burnout among primary care workers
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Individuals' characteristics associated with severe burnout
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Team factors associated with severe burnout
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Primary care center factors associated with severe burnout
Number of subjects: 2940
Study: 35013782

Group type: EXPERIMENTAL
Intervention: Transcrestal sinus floor elevation (tSFE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lateral sinus floor elevation (lSFE)
Number of subjects: 45
Study: 34330855

Group type: EXPERIMENTAL
Intervention: ACTI-MOBIL (mobile technology)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ACTI-VISIO (videoconferencing)
Number of subjects: 120

Group type: COMPARATOR
Intervention: CONTROL (standard care)
Number of subjects: 120
Study: 32680475

Group type: EXPERIMENTAL
Intervention: Behavioural group counselling program for smoking cessation, optional nicotine replacement therapy, environmental smoking reduction measures
Number of subjects: 416

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 416
Study: 33513064

Group type: EXPERIMENTAL
Intervention: Remote Hypnotic Induction Profile (rHIP)
Number of subjects: 56
Study: 32950505

Group type: EXPERIMENTAL
Intervention: Instagram use during presentation of new information
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Instagram use after presentation of new information
Number of subjects: 45

Group type: COMPARATOR
Intervention: No Instagram use (control group)
Number of subjects: 45
Study: 34438089

Group type: EXPERIMENTAL
Intervention: UAVS
Number of subjects: 40

Group type: COMPARATOR
Intervention: EVLA
Number of subjects: 40
Study: 32533985

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer 2–5 h after thaw (Group D2)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer 18–24 h after thaw (Group D2/D3)
Number of subjects: 388
Study: 33933666

Group type: EXPERIMENTAL
Intervention: No Practice Effects (NPE) cognitive battery
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Miami Computerized Functional Assessment Scale (CFAS)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Preclinical Alzheimer Cognitive Composite (PACC)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Alzheimer's Disease Assessment Scale‐Cognitive Subscale (ADAS‐Cog)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Functional Activities Questionnaire (FAQ)
Number of subjects: 320
Study: 35907840

Group type: EXPERIMENTAL
Intervention: Resistance training intervention
Number of subjects: 15
Study: 33938765

Group type: EXPERIMENTAL
Intervention: Utility-value reflection (n = 39)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control picture-summarization task (n = 34)
Number of subjects: 73
Study: 34587534

Group type: EXPERIMENTAL
Intervention: Exergames with physiotherapy support
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard postoperative physiotherapy
Number of subjects: 71
Study: 33144592

Group type: EXPERIMENTAL
Intervention: Normal P conditions (7551 ppm)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Reduced P conditions (4459 ppm)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Limited P conditions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal P conditions
Number of subjects: 50
Study: 33442915

Group type: EXPERIMENTAL
Intervention: VR intervention (8 h within 2 weeks) plus 8-h occupational therapy (OT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (time-matched OT alone)
Number of subjects: 23
Study: 33080380

Group type: EXPERIMENTAL
Intervention: Rubber Band Ligation (RBL)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Sutured Mucopexy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Haemorrhoidectomy
Number of subjects: 558

Group type: COMPARATOR
Intervention: Cost-effectiveness analysis
Number of subjects: 558

Group type: COMPARATOR
Intervention: Secondary outcomes
Number of subjects: 558
Study: 35511704

Group type: EXPERIMENTAL
Intervention: Glepaglutide 1 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Glepaglutide 10 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study: 34137527

Group type: EXPERIMENTAL
Intervention: Articaine 4% IANB with Buccal Infiltration
Number of subjects: 160

Group type: COMPARATOR
Intervention: Lidocaine 2% IANB with Buccal Infiltration
Number of subjects: 160
Study: 32912952

Group type: EXPERIMENTAL
Intervention: Personalised incentives (four schemes: Standard, Descending, Ascending, Deposit)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 220
Study: 34978076

Group type: EXPERIMENTAL
Intervention: 15 mg INCB054707 QD (Study 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30 mg INCB054707 QD (Study 2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 60 mg INCB054707 QD (Study 2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 90 mg INCB054707 QD (Study 2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (Study 2)
Number of subjects: 45
Study: 34608858

Group type: EXPERIMENTAL
Intervention: Newer non-wearable device (Beddit 3.5)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Early version of the non-wearable device (Beddit 3.0)
Number of subjects: 35
Study: 32728734

Group type: EXPERIMENTAL
Intervention: HERO intervention (8-session cognitive-behavioral therapy)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 34
Study: 34325950

Group type: EXPERIMENTAL
Intervention: Circulating homocysteine levels
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Circulating vitamin B6 levels
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Circulating vitamin B12 levels
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Circulating folate acid levels
Number of subjects: 27
Study: 35436524

Group type: EXPERIMENTAL
Intervention: Trial participants (EORTC boost-no boost trial)
Number of subjects: 20880

Group type: COMPARATOR
Intervention: Non-trial participants
Number of subjects: 20880
Study: 33930498

Group type: EXPERIMENTAL
Intervention: Vegetarians
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Vegans
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Flexitarians
Number of subjects: 412

Group type: COMPARATOR
Intervention: Omnivores
Number of subjects: 412
Study: 32645227

Group type: EXPERIMENTAL
Intervention: Blood flow restriction‐empowered low‐intensity interval walking exercise (BFR‐W)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional intensive overground walking (CON‐W)
Number of subjects: 24
Study: 35526858

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 34226018

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) mapping
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: FDG‐PET/CT imaging
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Completion pelvic lymphadenectomy
Number of subjects: 245
Study: 33198657

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 168
Study: 34501459

Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT) followed by conventional systemic treatment (FOLFOXIRI)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional chemotherapy (FOLFOXIRI)
Number of subjects: 90
Study: 32063448

Group type: EXPERIMENTAL
Intervention: rTMS (5‐Hz; 500 pulses/session; figure‐8 coil) on primary motor cortex
Number of subjects: 11
Study: 615704919

Group type: EXPERIMENTAL
Intervention: C1INH (20U/kg/dose) intra-operatively, then 2x weekly for 7 doses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: C1INH
Number of subjects: 20
Study: 35896583

Group type: EXPERIMENTAL
Intervention: Confidential digital certificate of very low capacity for transmitting SARS‐CoV‐2 (intervention group)
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Non-attendees (control group)
Number of subjects: 1351

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 1351

Group type: EXPERIMENTAL
Intervention: Survey respondents
Number of subjects: 1351
Study: 34398236

Group type: EXPERIMENTAL
Intervention: Romidepsin (RMD) 5 mg/m2 in multidose cohort 4
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Romidepsin (RMD)
Number of subjects: 59
Study: 32459776

Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum injections
Number of subjects: 70

Group type: COMPARATOR
Intervention: Percutaneous needle fasciotomy
Number of subjects: 70
Study: 32317748

Group type: EXPERIMENTAL
Intervention: 320 mg/day anthocyanin
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Anthocyanin supplementation (0-320 mg/day)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Anthocyanin supplementation (80-320 mg/day)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 32413002

Group type: EXPERIMENTAL
Intervention: Contrast-rebalanced binocular game treatment (1 hour a day, 5 days a week)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Patching treatment (2 hours a day, 7 days a week)
Number of subjects: 48
Study: 35730261

Group type: EXPERIMENTAL
Intervention: Acrylic resin anterior bite plane (ABP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Thermoplastic bite plane (TBP)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 66
Study: 33267812

Group type: EXPERIMENTAL
Intervention: Xerostomia
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Dysphagia
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Masticatory performance
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Number of functional teeth
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Occlusal condition
Number of subjects: 1076
Study: 36129891

Group type: EXPERIMENTAL
Intervention: Intraoperative VR in addition to monitored anesthesia care (MAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual MAC (control group)
Number of subjects: 40
Study: 33564957

Group type: EXPERIMENTAL
Intervention: AGV + Bevacizumab
Number of subjects: 63

Group type: COMPARATOR
Intervention: AGV alone
Number of subjects: 63
Study: 33277819

Group type: EXPERIMENTAL
Intervention: Intensive statin therapy
Number of subjects: 4461

Group type: COMPARATOR
Intervention: Standard statin therapy
Number of subjects: 4461

Group type: EXPERIMENTAL
Intervention: 1-year eGFR decline
Number of subjects: 4461
Study: 32444872

Group type: EXPERIMENTAL
Intervention: MIBT-APBI (multicatheter interstitial brachytherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3D-CRT-APBI (three-dimensional conformal external beam radiotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative APBI techniques (intraoperative electrons, 50-kV x-rays)
Number of subjects: 0
Study: 33054371

Group type: EXPERIMENTAL
Intervention: Avatars displaying participant's own face
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Avatars displaying participant's own face wearing sports clothes
Number of subjects: 305

Group type: COMPARATOR
Intervention: Avatars displaying stranger's face wearing formal clothes
Number of subjects: 305
Study: 32975024

Group type: EXPERIMENTAL
Intervention: Tamsulosin + Mirabegron
Number of subjects: 566

Group type: COMPARATOR
Intervention: Tamsulosin + Placebo
Number of subjects: 566
Study: 32832978

Group type: COMPARATOR
Intervention: Fremanezumab (quarterly or monthly dosing)
Number of subjects: 0
Study: 35152754

Group type: EXPERIMENTAL
Intervention: Endoscopic Combined Intrarenal Surgery (ECIRS)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Percutaneous Nephrolithotomy (PCNL)
Number of subjects: 6
Study: 33893671

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Zinc (30 mg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Zinc and Curcumin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 32530124

Group type: EXPERIMENTAL
Intervention: Collagen drink
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32597041

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy (COT)
Number of subjects: 60
Study: 36599608

Group type: EXPERIMENTAL
Intervention: Aficamten
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 34591428

Group type: EXPERIMENTAL
Intervention: Regional radiation therapy 50‐55 Gy and intermediate dose of α2b‐interferon (RT + IFN)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intermediate dose of α2b‐interferon alone (IFN)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: RT + IFN
Number of subjects: 96

Group type: COMPARATOR
Intervention: IFN
Number of subjects: 96
Study: 32866951

Group type: EXPERIMENTAL
Intervention: Prenatal surgery
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard postnatal repair
Number of subjects: 183
Study: 35832433

Group type: EXPERIMENTAL
Intervention: Laser-assisted zona thinning (LAT)
Number of subjects: 315
Study: 34666794

Group type: EXPERIMENTAL
Intervention: Improved mosquito proof polyvinyl chloride (PVC) lids
Number of subjects: 332

Group type: COMPARATOR
Intervention: Iron lids (control)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Pre-intervention survey
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Post-intervention survey
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Community awareness assessment
Number of subjects: 332
Study: 35416447

Group type: EXPERIMENTAL
Intervention: Exp2% (experimental SE + 2% biosilicate)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exp5% (experimental SE + 5% biosilicate)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exp2% and Exp5%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Exp0% (negative control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: AdheSE (positive control)
Number of subjects: 20
Study: 35726226

Group type: EXPERIMENTAL
Intervention: Painless rehabilitation care
Number of subjects: 124
Study: 33289072

Group type: EXPERIMENTAL
Intervention: Intact FGF23 levels
Number of subjects: 2376

Group type: EXPERIMENTAL
Intervention: Intact FGF23 levels in the highest quartile
Number of subjects: 2376
Study: 36087070

Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 1559

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1559
Study: 32796734

Group type: EXPERIMENTAL
Intervention: High-SDS diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low-SDS diet
Number of subjects: 8
Study: 34936847

Group type: EXPERIMENTAL
Intervention: Cluster 1 (high time adherence, n=75)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cluster 2 (low time adherence, n=23)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both clusters
Number of subjects: 98
Study: 35359881

Group type: EXPERIMENTAL
Intervention: Collaborative Nursing Intervention (CNI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine Nursing (Control Group)
Number of subjects: 72
Study: 33481052

Group type: EXPERIMENTAL
Intervention: SPP-24 levels measured in serum using ELISA; mean SPP-24 was 167.7 ± 101.1 ng/mL (range 33.4–633.6 ng/mL)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: SPP-24 levels measured in serum; adjusted for age, eGFR, and sex
Number of subjects: 192
Study: 32057442

Group type: EXPERIMENTAL
Intervention: PEG + DTZ
Number of subjects: 48

Group type: COMPARATOR
Intervention: PEG + Placebo
Number of subjects: 48
Study: 34269493

Group type: EXPERIMENTAL
Intervention: Online Acceptance and Commitment Therapy (ACT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Online Compassion-Focused Therapy (CFT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (not specified, but implied as inactive controls in previous studies)
Number of subjects: 49